Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 13/20 | 0.62 |
| ▸ | ADRA1D | P25100 | 12/20 | 0.62 |
| ▸ | ADRA1B | P35368 | 12/20 | 0.62 |
| ▸ | HTR1A | P08908 | 12/20 | 0.62 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | DRD4 | P21917 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.51 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.51 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9526823 | 0.94 | HTR1A (0.64) | ADRA1AADRA1DADRA1BHTR1ADRD2 | |
| SCHEMBL9527725 | 0.93 | HTR1A (0.60) | ADRA1AADRA1DADRA1BHTR1ADRD2 | |
| SCHEMBL9527250 | 0.92 | HTR1A (0.59) | ADRA1AADRA1DADRA1BHTR1ADRD2 | |
| SCHEMBL9527339 | 0.91 | HTR1A (0.66) | ADRA1AADRA1DADRA1BHTR1ADRD2 | |
| SCHEMBL9527540 | 0.89 | ADRA1A (0.54) | ADRA1AADRA1DADRA1BHTR1ADRD2 | |
| SCHEMBL9527688 | 0.88 | HTR1A (0.62) | ADRA1AADRA1DADRA1BHTR1ADRD2 | |
| SCHEMBL9527012 | 0.88 | HTR1A (0.56) | ADRA1AADRA1DADRA1BHTR1ADRD4 | |
| SCHEMBL9526993 | 0.88 | ADRA1D (0.49) | ADRA1AADRA1DADRA1BHTR1ADRD2 | |
| SCHEMBL9528052 | 0.87 | ADRA1B (0.53) | ADRA1AADRA1DADRA1BHTR1A | |
| SCHEMBL9527589 | 0.87 | ADRA1B (0.51) | ADRA1AADRA1DADRA1BHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0372305-B1 | PIPERAZINYLALKYL-3(2H)-PYRIDAZINONES, METHOD FOR THEIR PREPARATION AND THEIR USE AS ANTIHYPERTENSIVE AGENTS | Hafslund Nycomed Pharma Aktiengesellschaft (AT) | 1993-08-04 | — | — | EP | disclosed |
| US-5034391-A | Piperazinylalkyl-3(2H)-pyridazinones and the use thereof as agents lowering blood pressure | CL PHARMA AKTIENGESELLSCHAFT (AT) | 1991-07-23 | — | — | US | disclosed |
| EP-0372305-A1 | Piperazinylalkyl-3(2H)-pyridazinones, method for their preparation and their use as antihypertensive agents | Hafslund Nycomed Pharma Aktiengesellschaft (AT) | 1990-06-13 | — | — | EP | disclosed |